Each one in plain English, with the numbers worked through for a shareholder.
14 Mar 2025half year report● Neutral
Half-year to 31 December 2024: loss of $344,121 (prior-year half: $1,439,781) and net assets of $8,368,839 (June 2024: $8,276,617). Notes 15M shares issued on Biddle's performance rights conversion and 13,144,444 to Pioneer; Oasis consideration is $200,000 plus 20M shares.
Conference presentation by Executive Chairman Neil Biddle on the bitumen, geothermal and uranium assets. Based on the visible text, only disclaimers and competent person statements; no new results are apparent.
The sale of EP145 to Mosman completed, with Greenvale receiving $250,000 plus GST and all conditions met. This closes the Amadeus Basin exit agreed in October. The company says it, with the R&D rebate, is funded for Alpha Test Program 6 Stage 1 and Oasis exploration.
13 Jan 2025asset acquisition disposition▲ GoodMajor
Greenvale acquired 100% of the Oasis Uranium Project (EPM 27565, 90km2, Queensland, 50km west of Greenvale) for $200,000 cash and 20 million shares. Historic drilling reported intercepts up to 1m @ 0.72% U3O8. A new Queensland uranium asset, beyond the four NT projects; the company expects it to be upgraded to resource status in the 2025 season.
Greenvale terminated the Pioneer subscription facility early, paying $2 million cash plus 13,144,444 shares at $0.022 for the balance. It expects about $1.9M cash and receivables afterwards; the $3M director loan remains undrawn. This closes the 2023 prepayment arrangement, at the cost of cash and some dilution.
20 Nov 2024asset acquisition disposition▲ GoodMajor
Greenvale signed a binding agreement with Gempart for an initial 80% of the Elkedra Uranium Project (EL33756, 566km2, NT), free-carried to a feasibility study, for about $10,000. The fourth NT uranium project after Douglas River, Tobermorey and Henbury; shallow drill targets cited.
Presentation for the 20 November 2024 AGM, positioning Greenvale around Alpha bitumen, Queensland geothermal and Northern Territory uranium projects. Based on the visible text, it carries no new figures or results beyond what was already announced.
19 Nov 2024director officer appointment● NeutralMajor
CEO Mark Turner resigned as director and will step down as CEO at year end, possibly staying as Alpha consultant. Chairman Neil Biddle becomes Executive Chairman with no change to his pay, while the company pursues uranium and Alpha Test Program 6.
Airborne radiometric surveys totalling 14,511 line-km over Henbury, Tobermorey and Douglas River East confirmed the uranium anomalies seen in older government surveys. Maiden drilling is targeted for April 2025, after the wet season; Douglas West survey delayed.
Lab-scale Test Program 5 gave bitumen yields above 30 wt% and improved viscosity; with further tuning, C170-range viscosity could be achievable. This partly answers June's Technix setback. Penetration tests could not be done on small samples; bulk testing may follow.
21 Oct 2024asset acquisition disposition▲ GoodMajor
Greenvale signed a binding agreement with Gempart for an initial 80% of the Henbury Uranium Project (Amadeus Basin, NT), on the same free-carry terms, for about $10,000 upfront. This is the third uranium project in weeks.
16 Oct 2024asset acquisition disposition● NeutralMajor
Greenvale agreed to sell its 75% EP145 helium/hydrogen farm-in interest to Mosman for $250,000, full reimbursement of its costs. This ends the Amadeus Basin push of October 2023, redirecting effort to uranium. Conditional on ministerial consent.
16 Oct 2024asset acquisition disposition▲ GoodMajor
Greenvale signed a binding agreement with Gempart for an initial 80% of the Tobermorey Uranium Project (NT), free-carried to a feasibility study, for about $10,000 upfront. A second uranium project after Douglas River; it can withdraw at any time.
Peter Harding-Smith, a chartered accountant, was appointed Chief Financial Officer and Company Secretary, replacing joint secretaries Kurt Laney and Vince Fayad. The registered office moved to Brisbane.
Appendix 4G corporate governance checklist lodged with the annual report for the year to 30 June 2024. Administrative filing with no new information on the business.
Annual report for year to 30 June 2024. The Chairman calls the year one of mixed fortune with slower-than-expected progress; Alpha studies are on hold pending Test Program 5, EP145 was delayed by approvals, and Douglas River uranium was added. Financial figures not visible in the text.
Astute Metals irrevocably exercised its call option over Greenvale's 2% Georgina Basin royalty. SRK will value it, and Astute may pay in cash or shares (VWAP estimated at $0.029). Price is not yet set; settlement terms still to be agreed.
Greenvale re-released its 28 August Douglas River uranium announcement, amended to add information required under JORC. The deal is unchanged: initial 80% of the Pine Creek, NT project, Gempart free-carried to a feasibility study, about $20,000 upfront.
CEO Mark Turner presented at the Resources Rising Stars conference on the Gold Coast on 3 September. The visible text is the notice and disclaimers; no new results are visible. Presentation is titled around bitumen and uranium assets.
28 Aug 2024asset acquisition disposition▲ GoodMajor
Greenvale signed a binding agreement to acquire an initial 80% of the Douglas River Uranium Project (Pine Creek, NT) from Gempart, which is free-carried to a feasibility study. Upfront cost is about $20,000. This is the new-asset push flagged in June, and a move into uranium.
A six-month extension was approved for EP145 Year 3 work, now due 21 February 2025, because environmental approvals for the seismic survey are delayed. This contrasts with the earlier plan of August start; Year 4 well drilling is due by February 2026.
Greenvale received the $0.83M 2023 R&D tax rebate, as flagged on 16 July, bringing cash to about $3.70M. Funds are earmarked for Alpha test work and new business development opportunities.
Greenvale re-engaged the University of Jordan for a low-cost, lab-scale Test Program 5 to fix the viscosity and elasticity problems Technix found at Alpha. If successful, Test Program 6 would follow. No guarantee of a positive outcome.
16 July 2024asset acquisition disposition● NeutralMajor
Greenvale sold its Astute Metals shareholding for $1.53M, lifting cash to over $2.85M. It keeps the 2% royalty and the possible 5M-share milestone payment. About $830,000 of 2023 R&D grant is expected soon.
Technix testwork found Alpha shale extract can make standard or modified bitumen but not premium C170 grade. The Board suspended the Alpha Scoping Study to re-evaluate and conserve cash, and is assessing new acquisitions. This reverses the earlier PFS-then-pilot path.
14 June 2024capital raising announcement▼ BadMajor
Greenvale withdrew the 7 June $1.9M Share Purchase Plan at 5c, citing uncertain markets and the recent share price decline. It may raise again once Alpha updates are out, and is reviewing new acquisition opportunities.
Greenvale won a $100,000 NT Government co-funding grant toward one seismic line in the EP145 Wild Horse 2D survey, still scheduled to start in August. A modest endorsement and a small offset to cost.
Greenvale issued 18.5M shares to Pioneer at 5.4c, cutting the loan from $3.287M to $2.287M, and planned a $1.9M SPP at 5c (38M shares). The Alpha PFS is now to be revised to a Scoping Study. Full Pioneer repayment deferred to conserve cash. Test Program 4 testing complete.
4 June 2024asset acquisition disposition● NeutralMajor
The sale of Greenvale's remaining 20% of Knox (Georgina Basin) to Astute completed, for 5M Astute shares, resolving the January term sheet. A further 5M shares are possible on milestones within four years. Stake in Astute is now 12.27%; the 2% royalty is kept.
Greenvale launched an online Investor Hub where shareholders can find announcements and presentations and ask management questions. No new results or financial information.